Demonstrates cost-saving clinical effectiveness of DCB angioplasty over PB angioplasty, indicating a shift towards value-based care.
Despite the higher device cost, DCB angioplasty appeared to be a cost-saving and clinically more effective alternative to PB angioplasty in this cohort. Lower overall institutional expenditure and reduced reintervention frequency support its consideration for integration into AVF maintenance protocols and value-based care pathways in similar fixed-reimbursement settings.
No takes yet. Share an insight, caveat, or question.
Lučev et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: